Good Intentions: How Big Business and the Medical Establishment Are Corrupting the Fight Against AIDS

Bruce Nussbaum, Author
Bruce Nussbaum, Author Grove/Atlantic $22.95 (352p) ISBN 978-0-87113-385-4
Reviewed on: 10/01/1990
Release date: 10/01/1990
Business Week writer Nussbaum blames the failure to find a drug effective against AIDS on an unholy alliance forged among the National Institutes of Health, the FDA, elite biomedical centers and the big drug companies. AZT, the toxic, immunosuppressive anti-AIDS drug developed by Burroughs Wellcome, probably offers only short-term, transitory benefits to some patients, he charges. A hard-hitting, shocking look at profit-oriented AIDS research, this brisk journalistic account also tours a medical underground in which grass-roots organizations offer various unapproved drugs to people with AIDS. In this informal network, claims Nussbaum ( The World After Oil ), a model for quick testing of drugs is emerging that, if widely implemented, could revolutionize the treatment of other diseases. Photos. (Oct.)
The Best Books, Emailed Every Week
Tip Sheet!
MORE BOOKS YOU'D LIKE
X